Emai:marketing@yakkaa.com
業務谘詢專線:400-780-8018
Tel: +1(626)986-9880(U.S. - West Coast)
0044 7790 816 954 (Europe)
Email: marketing@medicilon.com
地址:上海市浦東新區川大路585號
郵編:201299
電話:+86 (21) 5859-1500(總機)
傳真:+86 (21) 5859-6369
© 2023 上海hjc黄金城生物醫藥股份有限公司 保留所有權利 滬ICP備10216606號-3
滬公網安備 31011502018888號 | 網站地圖
業務谘詢
中國:
Email: marketing@yakkaa.com
業務谘詢專線:400-780-8018
(僅限服務谘詢,其他事宜請撥打川沙總部電話)
川沙總部電話: +86 (21) 5859-1500
海外:
+1(626)986-9880(U.S. - West Coast)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
hjc黄金城匯總整理了12月生物醫藥行業會議供參考交流。同時,我們將計劃參與海內外5場會議:
- “SLAS-ELRIG Networking Event”
- “Genesis 2023”
- "Mediclon Boston Opening"
- “ASH 2023”
- “2023深圳灣實驗室轉化醫學高峰論壇”
marketing@yakkaa.com
媒體與會務請聯係微信或郵箱
Ready to Meet Medicilon at SLAS-ELRIG Networking Event?
Revolutionary Adhesion: Unveiling the Power of Molecular Glues in Medicine, Science and Beyond!
We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities.
Proteolysis targeting chimeras (PROTACs) offer a fast and reversible chemical knock-down approach to control protein function. PROTAC technology takes advantage of a moiety of targeted protein and a moiety of recognizing E3 ubiquitin ligase and produces a hybrid molecule to specifically knock down a targeted protein.
Medicilon provides PROTAC drug discovery, CMC research (API + formulation), pharmacodynamics research, PK study, safety evaluation and other services. Medicilon’s PROTAC drug discovery technology platform covers the currently popular target protein ligands. We have established a linker system with an extensive collection of bifunctional linkers. Together with our expanding E3 ubiquitin ligase binder library, we can efficiently synthesize a substantial amount of highly active PROTAC bispecific small molecules, which would have the potential to significantly facilitate the drug discovery and development process. As of the end of June 2023, Medicilon has successfully assisted in the clinical approval of 5 PROTAC drugs and has 20+ PROTAC projects under development.
Date: Tuesday 5 December 2023 from 10:00 -18:00
Location: 1 Wimpole Street, London, W1G 0AE
Join Medicilon at Genesis 2023!
Fostering Innovation, Investment, and Deal-making at Genesis 2023.
For over two decades, the annual Genesis conference has brought key Life Science opinion leaders and stakeholders together to debate key trends, instigate deals and generate a vision of the future.
By facilitating critical networking, and sharing the latest insights in the Life Sciences industry, One Nucleus' Genesis 2023 & Genesis Fringe Seminars can help you and your organization along your journey to success. 300 delegates from across the industry attend Genesis, and this year is expected to achieve the same on 5-8 December in Central London. Between the insightful keynote sessions are valuable breaks where you can continue the exciting stimulating discussions, and meet contacts old and new.
Dr. Jing Deng, our VP of Pharmacology, Pharmacodynamics and Biology Department, will give a great presentation titled "New technology platforms in preclinical research" in Genesis Fringe Seminar on December 5th, 2023, 18:00-21:00 pm.
InnoXBio生物醫藥產業生態圈大會暨首屆大灣區細胞基因治療發展論壇定於2023年12月7-8日,在廣州知識城國際會展中心召開,大會將邀請CGT產業上下遊行業專家,以主題演講、圓桌討論、產品展示等形式分享行業成果與前沿動態,把握產業發展脈搏,攜手各方,共築產業興!
Celebrate Mediclon Boston Opening!
Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D service for pharmaceutical enterprises and scientific research institutions around the world. We are excited to invite you to the Medicilon Boston Site Opening Reception for a great time of lunch, networking, and discussion.
The theme of this event is to share hopes and bright future of biomedicine. With the opening its Boston site, Medicilon is committed to working ever closely with our partners in their pursuit of finding cures for patients in need.
Date: December 9th, 2023 (Saturday)
Time:11:00 am - 2:00 pm
Venue: Medicilon Boston Site (50 Soldiers Field Place, Boston, MA 02135)
We look forward to meeting you at ASH 2023!
With more than 18,000 members from nearly 100 countries, ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases. Fostering high-quality, equitable care, transformative research, and innovative education to improve the lives of patients with blood and bone marrow disorders.
Medicilon team are present throughout the conference.
Medicilon translational medicine platform is committed to providing global partners with comprehensive biomarker discovery, target integrated solutions for point-of-care verification, companion diagnostic development, and commercial testing.
We look forward to welcoming you in San Diego!
Date: December 9-12, 2023
Location: San Diego
由深圳市坪山區科技創新局指導,南方科技大學坪山生物醫藥研究院和化學化工專業委員會聯合主辦,深圳市坪山區小分子新藥創聯協會、藥渡經緯信息科技(北京)有限公司、銀星坪山生命健康科技園聯合承辦,深圳市坪山區產業資本投資有限公司、貝殼學社、深圳市生命科學與生物技術協會、深圳市坪山區高層次人才協會、深圳市華先醫藥科技有限公司、深圳艾欣達偉醫藥科技有限公司、深圳安泰維生物醫藥有限公司、深圳格林凱特醫藥技術有限公司、化學加聯合協辦的“2023深圳生物醫藥產業創新發展高峰論壇暨化學化工專業委員會年會”,擬定於2023年12月10日在深圳市坪山銀星生命健康產業園舉辦。
本次會議以“醫藥創新加速、轉化助力共贏”為主題,匯聚國內外有實戰轉化經驗的科研院所、創新藥企、生物科技公司、投資公司、CXO等生態群體,助力科研機構醫藥創新與轉化,致力於打造中國醫藥創新和轉化領域頂尖的行業盛會。
參會嘉賓將就“新型科研機構如何進行轉化”“醫藥資本市場對創新藥開發方向”“創新藥源頭開發策略”以及“科研機構如何同藥企進行更好的合作”等問題共同思考、分享實踐、探尋方法。
由長三角企業家聯盟、浙江省工商業聯合會指導,杭州市濱江區人民政府、長三角數據驅動創新生物醫藥產業鏈聯盟、中國生物醫藥產業鏈創新轉化聯合體主辦,火石數鏈、貝達藥業、南京生物醫藥創新轉化中心、藥咖薈承辦的“長三角生物醫藥產業大會”將於2023年12月14-16日在杭州召開。
本次大會以“數智時代 醫藥生存與創新”為主題,整合長三角地區IT+BT資源,交流探討數字技術賦能生物醫藥產業數字化轉型新路徑與新經驗,推進產業大數據及數字技術在藥物發現、設計、研發、臨床研究、質量檢測、全鏈條管理等數字化場景應用創新。通過數據驅動+產業互聯,把產業數字化治理與藥械企業創新生態構建相結合,以數據流帶動業務流,推動數據要素價值化,醫藥營銷合規化,打造服務全國的產業服務交流平台,實現數據驅動全要素生產率和醫藥產業資源配置效率的提升,助力長三角數字化發展之路走深走實,共築產業新生態。
生物醫藥作為中國七大戰略性新興產業之一,是健康中國建設的重要基礎,也是寧波市重點聚焦的戰略性新興產業。為深入推進生物醫藥產業高質量快速發展,優化全球臨床開發和跨境合作,促進技術成果推介和供需對接,“第二屆中國•寧波生物醫藥產業發展大會”暨“第三屆新藥創業在前灣項目路演&投融資洽談會”將於2023年12月15-17日在前灣新區寧波杭州灣凱悅酒店舉辦。
會議將圍繞創新藥研發、細胞基因療法、AI與合成生物學、小核酸藥物研發、中藥現代化等專題進行探討交流,深度融合行業資源和產業資本,共同推進生物醫藥產業的蓬勃發展。誠摯地邀請您撥冗出席本次盛會!
作為中國生物醫藥四大聚集地之一,京津冀地區已成為我國生物醫藥產業發展重要集聚地之一,初步形成了以北京為核心、天津和河北互補協作的產業協同發展格局。其中北京生物醫藥產業創新優勢突出,初步形成了“一南一北、各具特色”的空間布局。“南”包括以亦莊和大興生物醫藥基地為核心的高端產業基地,“北”包括以中關村生命科學園為核心的研發創新中心。
其中RNA療法產業華北論壇將聚焦RNA療法突破,關注小核酸藥物開發、mRNA新型傳染病疫苗、mRNA新型癌症疫苗等產品的開發,大會將於12月27日-28日在北京舉辦,基於前三屆RNA療法與新型疫苗產業峰會,本次峰會將吸引超過1300人次參會嘉賓。
marketing@yakkaa.com
微信或郵件聯係我們